We report a case of a 47-year-old woman with history of papillary thyroid cancer whose diagnosis of melanoma led to cancer genetics evaluation revealing a pathogenic PMS2 variant and subsequent identification of endometrial cancer. This evidence concerns the gene PMS2 and endometrial cancer.